
Paediatric anaesthesia in Europe: the APRICOT study
One of the sessions on the final day of this year’s Euroanaesthesia meeting was dedicated to another successful study from the ESA’s Clinical Trials Network (CTN) – the APRICOT study.
On 28 March 2017, APRICOT (Anaesthesia PRactice In Children Observational Trial) was published in The Lancet Respiratory Medicine. The primary endpoint of this trial was incidence of severe critical events, defined by incidents occurring during and up to 60 minutes after anaesthesia or sedation (laryngospasm, bronchospasm, pulmonary aspiration, drug error, anaphylaxis, cardiovascular instability, neurological damage, cardiac arrest and post-extubation stridor) during and immediately following anaesthesia (PACU).